HIV-1 protease inhibitors (Kyoto University)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHIV-1 protease inhibitors (Kyoto University)
Drug Alias NameKMI-272TAN-1364BRK-682
ClassificationSmall molecules
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitors
TargetsHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyoto University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyoto University
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A